3 Int'l Patent Developments Attys Should Know About
CRISPR Patent Takes Hit in Europe
The closely watched fight over breakthrough gene-editing technology CRISPR took another turn this month when the European Patent Office revoked a patent held by the Broad Institute.
In a decision on Jan. 17, the EPO’s Opposition...
To view the full article, register now.